How do you build patient segments in a largely underdiagnosed population?
Challenge How do you build patient segments in a largely underdiagnosed population? See how one brand team used a novel way to quantify and understand meaningful patient...
How can we increase treatment access through commercial targeting when prescribing influence is complex?
Challenge How can we increase treatment access through commercial targeting when prescribing influence is complex? A pharma brand team was launching a new mechanism of action for...
Which oncology KOLs should we prioritize for a variety of launch planning use cases?
Challenge Which oncology KOLs should we prioritize for a variety of launch planning use cases? The oncology team at a large pharmaceutical company was gearing up for multiple...
How can we size our potential market when the population is difficult to define?
Challenge Market Sizing: How can we size our potential market when the population is difficult to define? A launch planning team for a new metabolic treatment faced a big question: How...
Maturing cardio brand uses patient journey analysis to find new revenue streams within an established standard of care
Challenge The brand director in the lifecycle management division of a large pharmaceutical company was challenged to find new revenue opportunities for a cardiology drug that had reached maturity in...
Pharmaceutical company gets fast real-world market insights in readiness to launch newly acquired drug
Challenge A mid-sized pharmaceutical company acquired the U.S. rights for a product in a market with just one competitor, but was lacking the market knowledge to position the drug. Before starting...
Oncology team extends presence in the treatment pathway using epidemiology and claims data analysis
Challenge The oncology team at a large pharmaceutical company was looking to optimize market position on several fronts: Defend its territory as a first-line therapy for indication #1 Uncover...
Case Study: Oncology Clinical Trial Monitor
Challenge: The chief strategy officer at a large pharmaceutical company needs to have up-to-date knowledge regarding broad trends in immuno-oncology development activities. The chief strategy officer...
Case Study: Mapping the Clinical Path in Rheumatoid Arthritis with Real World Data
Case Study: Mapping the Clinical Path in Rheumatoid Arthritis with Real World Data The growing accessibility of healthcare Real World Data (RWD) has opened up previously unimaginable resources for...
Connect